Susquehanna International Group, LLP Biotechnology

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CRTX Cortexyme, Inc.	$70.5M	$41,000 0.0% of portfolio	32,553	Q3 2024 Reduced 66.99%
CARA Cara Therapeutics, Inc.	$15.6M	$39,000 0.0% of portfolio	127,553	Q3 2024 Reduced 31.37%
ENTX Entera Bio Ltd.	$48.7M	$39,000 0.0% of portfolio	20,658	Q3 2024 Reduced 28.41%
QSI Quantum Si Inc	$136M	$38,000 0.0% of portfolio	44,029	Q3 2024 Reduced 67.41%
NUVB Nuvation Bio Inc.	$628M	$33,000 0.0% of portfolio	14,485	Q3 2024 Reduced 28.64%
IVA Inventiva S.A.	$110M	$30,000 0.0% of portfolio	16,327	Q3 2024 New
CLLS Cellectis S.A.	$91.9M	$27,000 0.0% of portfolio	13,010	Q3 2024 New
HLVX Hille Vax, Inc.	$65.5M	$26,000 0.0% of portfolio	14,925	Q3 2024 New
CLSD Clearside Biomedical, Inc.	$65.6M	$25,000 0.0% of portfolio	20,319	Q3 2024 New
VINC Vincerx Pharma, Inc.	$5.72M	$23,000 0.0% of portfolio	31,980	Q3 2024 New
ALVR Allovir, Inc.	$49.3M	$22,000 0.0% of portfolio	27,213	Q3 2024 Reduced 83.81%
BRTX Bio Restorative Therapies, Inc.	$5.4M	$22,000 0.0% of portfolio	12,774	Q3 2024 New
FGEN Fibrogen Inc	$38.4M	$22,000 0.0% of portfolio	55,362	Q3 2024 Reduced 88.54%
BTAI Bio Xcel Therapeutics, Inc.	$12M	$20,000 0.0% of portfolio	34,207	Q3 2024 Reduced 80.26%
RAPT Rapt Therapeutics, Inc.	$34.4M	$20,000 0.0% of portfolio	10,202	Q3 2024 Reduced 8.37%
TNYA Tenaya Therapeutics, Inc.	$148M	$19,000 0.0% of portfolio	10,339	Q3 2024 Reduced 75.97%
IFRX Infla Rx N.V.	$108M	$18,000 0.0% of portfolio	12,374	Q3 2024 New
IMAB I Mab	$84.8M	$16,000 0.0% of portfolio	13,351	Q3 2024 Reduced 57.02%
ATAI Atai Life Sciences N.V.	$280M	$15,000 0.0% of portfolio	13,337	Q3 2024 Reduced 51.74%
BNOX Bionomics Limited	$2.18M	$15,000 0.0% of portfolio	34,138	Q3 2024 New
EYEN Eyenovia, Inc.	$3.08M	$15,000 0.0% of portfolio	29,904	Q3 2024 Reduced 65.76%
ACHL Achilles Therapeutics PLC	$43.6M	$12,000 0.0% of portfolio	12,434	Q3 2024 New
CTMX Cytom X Therapeutics, Inc.	$71.9M	$12,000 0.0% of portfolio	10,304	Q3 2024 Reduced 60.25%
LCTX Lineage Cell Therapeutics, Inc.	$100M	$10,000 0.0% of portfolio	10,996	Q3 2024 Reduced 84.58%
BLRX Bio Line Rx Ltd.	$17.8M	$9,000 0.0% of portfolio	18,032	Q3 2024 Reduced 84.74%
KZR Kezar Life Sciences, Inc.	$507M	$9,000 0.0% of portfolio	12,594	Q3 2024 Reduced 95.65%
ATHA Athira Pharma, Inc.	$24.2M	$8,000 0.0% of portfolio	18,351	Q3 2024 Reduced 70.32%
LYRA Lyra Therapeutics, Inc.	$6.68M	$3,000 0.0% of portfolio	12,913	Q3 2024 Reduced 63.27%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	147,291	Q3 2024 Added 477.59%
CELUW Celularity Inc Wt Exp 05/24/20	$0	$0 0.0% of portfolio	31,148	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.